Phenotypic expression of hereditary hemochromatosis: What have we learned from the population studies?

Current Gastroenterology Reports

Volumn 12, Issue 1, 2010, Pages 7-12

  Gan, Eng K ^a   Ayonrinde, Oyekoya T ^a   Trinder, Debbie ^a   Olynyk, John K ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Ferritin; Genotype; Hereditary hemochromatosis; HFE; Iron; Liver; Phenotype; Screening

Indexed keywords

HFE PROTEIN;

CLINICAL FEATURE; EARLY DIAGNOSIS; EARLY INTERVENTION; ETHNIC DIFFERENCE; FAMILY STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HEMOCHROMATOSIS; HLA TYPING; HUMAN; IRON OVERLOAD; LABORATORY TEST; LIVER BIOPSY; LIVER CIRRHOSIS; MUTATIONAL ANALYSIS; PENETRANCE; PHENOTYPE; PHLEBOTOMY; REVIEW;

EUROPE; FEMALE; GENES; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; IRON; IRON METABOLISM DISORDERS; MALE; PENETRANCE; PHENOTYPE; POPULATION GROUPS;

EID: 77950865630     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-009-0078-3     Document Type: Review

References (57)

1. A Trousseau 1865 Glycosurie; diabete sucre Clinique medicale de l'Hotel-Dieu de Paris 2 663 698
2. Sheldon JH: Hemochromatosis. London: Oxford University Press; 1935.
3. Finch SC, Finch CA: Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis. Medicine (Baltimore) 1955, 34:381-430.
4. RN MacSween AR Scott 1973 Hepatic cirrhosis: a clinico-pathological review of 520 cases J Clin Pathol 26 936 942 10.1136/jcp.26.12.936 4784502 1:STN:280:DyaE2c7isFSntg%3D%3D
5. WD Davis WR Arrowsmith 1952 The effect of repeated phlebotomies in hemochromatosis; report of three cases J Lab Clin Med 39 526 532 14917916
6. A Bomford R Williams 1976 Long-term results of venesection therapy in idiopathic haemochromatosis Q J Med 45 611 623 188063 1:STN:280: DyaE2s%2FnvFKisg%3D%3D
7. TH Bothwell I Cohen OL Abrahams SM Perold 1959 A familial study in idiopathic hemochromatosis Am J Med 27 730 738 10.1016/0002-9343(59)90189-5 13803128 1:STN:280:DyaF3c7itlGhsA%3D%3D
8. M Simon M Bourel B Genetet R Fauchet 1977 Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing N Engl J Med 297 1017 1021 909547 1:STN:280:DyaE1c%2FhtVeitQ%3D%3D (Pubitemid 8228323)
9. ML Bassett TJ Doran JW Halliday, et al. 1982 Idiopathic hemochromatosis: demonstration of homozygous-heterozygous mating by HLA typing of families Hum Genet 60 352 356 10.1007/BF00569217 7106771 1:STN:280:DyaL383mtlKisA%3D%3D (Pubitemid 12096393)
10. Dadone MM, Kushner JP, Edwards CQ, et al.: Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol 1982, 78:196-207.
11. ST Borwein CN Ghent PR Flanagan, et al. 1983 Genetic and phenotypic expression of hemochromatosis in Canadians Clin Invest Med 6 171 179 6652983 1:STN:280:DyaL2c%2Fot1ymug%3D%3D
12. BA Leggett JW Halliday NN Brown, et al. 1990 Prevalence of haemochromatosis amongst asymptomatic Australians Br J Haematol 74 525 530 10.1111/j.1365-2141.1990.tb06345.x 2346731 1:STN:280:DyaK3c3msl2qtA%3D%3D
13. PC Adams M Speechley AE Kertesz 1991 Long-term survival analysis in hereditary hemochromatosis Gastroenterology 101 368 372 2065912 1:STN:280:DyaK3M3ptlCqtQ%3D%3D
14. C Niederau R Fischer A Purschel, et al. 1996 Long-term survival in patients with hereditary hemochromatosis Gastroenterology 110 1107 1119 10.1053/gast.1996.v110.pm8613000 8613000 1:STN:280:DyaK287otlWnug%3D%3D (Pubitemid 26113751)
15. C Niederau R Fischer A Sonnenberg, et al. 1985 Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis N Engl J Med 313 1256 1262 4058506 1:STN:280:DyaL28%2FktVansw%3D%3D (Pubitemid 16217048)
16. S Fargion C Mandelli A Piperno, et al. 1992 Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis Hepatology 15 655 659 10.1002/hep.1840150417 1312985 1:STN:280:DyaK383gtFOrsw%3D%3D
17. JN Feder A Gnirke W Thomas, et al. 1996 A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 399 408 10.1038/ng0896-399 8696333 1:CAS:528:DyaK28XkslOnurg%3D (Pubitemid 26256612)
18. E Beutler T Gelbart C West, et al. 1996 Mutation analysis in hereditary hemochromatosis Blood Cells Mol Dis 22 187 194 10.1006/bcmd.1996.0027 8931958 1:CAS:528:DyaK28XntlGrtrY%3D (Pubitemid 26397324)
19. EC Jazwinska LM Cullen F Busfield, et al. 1996 Haemochromatosis and HLA-H Nat Genet 14 249 251 10.1038/ng1196-249 8896549 1:CAS:528:DyaK28XntVClsLs%3D
20. E Rossi S Henderson CY Chin, et al. 1999 Genotyping as a diagnostic aid in genetic haemochromatosis J Gastroenterol Hepatol 14 427 430 10.1046/j.1440-1746.1999.01884.x 10355506 1:STN:280:DyaK1M3otFKgtQ%3D%3D (Pubitemid 29256177)
21. BR Bacon JK Olynyk EM Brunt, et al. 1999 HFE genotype in patients with hemochromatosis and other liver diseases Ann Intern Med 130 953 962 10383365 1:STN:280:DyaK1M3psVertQ%3D%3D
22. PC Adams DM Reboussin JC Barton, et al. 2005 Hemochromatosis and iron-overload screening in a racially diverse population N Engl J Med 352 1769 1778 10.1056/NEJMoa041534 15858186 1:CAS:528:DC%2BD2MXjsFyhs7Y%3D (Pubitemid 40570925)
23. AT Merryweather-Clarke JJ Pointon JD Shearman KJ Robson 1997 Global prevalence of putative haemochromatosis mutations J Med Genet 34 275 278 10.1136/jmg.34.4.275 9138148 1:STN:280:DyaK2s3osVSksA%3D%3D
24. JK Olynyk DJ Cullen S Aquilia, et al. 1999 A population-based study of the clinical expression of the hemochromatosis gene N Engl J Med 341 718 724 10.1056/NEJM199909023411002 10471457 1:STN:280:DyaK1MzotlKhsw%3D%3D (Pubitemid 29407371)
25. E Beutler VJ Felitti JA Koziol, et al. 2002 Penetrance of 845G->A (C282Y) HFE hereditary haemochromatosis mutation in the USA The Lancet 359 211 218 10.1016/S0140-6736(02)07447-0 (Pubitemid 34113819)
26. Y Deugnier A-M Jouanolle J Chaperon, et al. 2002 Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: a study of 9396 French people Br J Haematol 118 1170 1178 10.1046/j.1365-2141. 2002.03718.x 12199803 1:CAS:528:DC%2BD38Xotlamsr4%3D (Pubitemid 35025987)
27. A Asberg K Hveem K Thorstensen, et al. 2001 Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65, 238 persons Scand J Gastroenterol 36 1108 1115 10.1080/003655201750422747 11589387 1:CAS:528:DC%2BD3MXns1Kiur0%3D (Pubitemid 32801699)
28. MB Delatycki KJ Allen AE Nisselle, et al. 2005 Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis The Lancet 366 314 316 10.1016/S0140-6736(05)63012-7 1:STN:280:DC%2BD2MzotlSmtA%3D%3D (Pubitemid 41019421)
29. JK Olynyk SE Hagan DJ Cullen, et al. 2004 Evolution of untreated hereditary hemochromatosis in the Busselton population: a 17-year study Mayo Clinic Proceedings 79 309 313 10.4065/79.3.309 15008603
30. RV Andersen A Tybjaerg-Hansen M Appleyard, et al. 2004 Hemochromatosis mutations in the general population: iron overload progression rate Blood 103 2914 2919 10.1182/blood-2003-10-3564 15070663 1:CAS:528:DC%2BD2cXjsVahu74%3D (Pubitemid 38451659)
31. Whitlock EP, Garlitz BA, Harris EL, et al.: Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive services task force. Ann Intern Med 2006, 145:209-223. (Pubitemid 46780566)
32. KJ Allen LC Gurrin CC Constantine, et al. 2008 Iron-overload-related disease in HFE hereditary hemochromatosis N Engl J Med 358 221 230 10.1056/NEJMoa073286 18199861 1:CAS:528:DC%2BD1cXms1OrsA%3D%3D This article presents data on the natural history of untreated disease in 203 newly diagnosed HFE C282Y homozygotes. It introduced for the first time the term "iron overload-related" diseases.
33. LC Gurrin NJ Osborne CC Constantine, et al. 2008 The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis Gastroenterology 135 1945 1952 10.1053/j.gastro.2008.08.056 18848943 1:CAS:528:DC%2BD1MXht1ertr8%3D This article presents data on penetrance and natural history of development of elevated iron parameters in untreated HFE C282Y homozygotes.
34. D Guyader C Jacquelinet R Moirand, et al. 1998 Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis Gastroenterology 115 929 936 10.1016/S0016-5085(98)70265-3 9753496 1:STN:280:DyaK1cvis1egtg%3D%3D (Pubitemid 28452941)
35. LW Powell JL Dixon GA Ramm, et al. 2006 Screening for hemochromatosis in asymptomatic subjects with or without a family history Arch Intern Med 166 294 301 10.1001/archinte.166.3.294 16476869 This article presents data on penetrance of liver disease and clinical symptoms in 672 newly diagnosed HFE C282Y homozygotes. (Pubitemid 43244317)
36. Olynyk JK, St Pierre TG, Britton RS, et al.: Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging. Am J Gastroenterol 2005, 100:837-841.
37. Z Shi D Johnstone BA Talseth-Palmer, et al. 2009 Haemochromatosis HFE gene polymorphisms as potential modifiers of hereditary nonpolyposis colorectal cancer risk and onset age International Journal of Cancer 125 78 83 10.1002/ijc.24304 1:CAS:528:DC%2BD1MXmslCgtb8%3D This article presents data on link between H63D homozygosity, MMR mutation, and colorectal cancer in HNPCC patients.
38. A Gunel-Ozcan S Alyilmaz-Bekmez EN Guler D Guc 2006 HFE H63D mutation frequency shows an increase in Turkish women with breast cancer BMC Cancer 6 37 10.1186/1471-2407-6-37 16503999 1:CAS:528:DC%2BD28XjtFCmuro%3D
39. • Osbourne NJ, Gurrin LC, Allen KJ, et al.: HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology 2009 (Epub ahead of print). This article presents data on link between C282Y homozygosity and colorectal and breast cancer in HH.
40. LR Zacharski BK Chow PS Howes, et al. 2008 Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial J Natl Cancer Inst 100 996 1002 10.1093/jnci/djn209 18612130 1:CAS:528:DC%2BD1cXoslGgtrg%3D (Pubitemid 352019800)
41. LC Gurrin NA Bertalli GW Dalton, et al. 2009 HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity Hepatology 50 94 101 10.1002/hep.22972 19554541 1:CAS:528:DC%2BD1MXpt1ShsLg%3D This article presents data on Iron-overload related disease in HFE compound heterozygotes.
42. E Rossi JK Olynyk DJ Cullen, et al. 2000 Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women Clin Chem 46 162 166 10657371 1:CAS:528:DC%2BD3cXjvFGht7o%3D (Pubitemid 30104238)
43. CC Constantine GJ Anderson CD Vulpe, et al. 2009 A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis Br J Haematol 147 140 149 10.1111/j.1365-2141.2009. 07843.x 19673882 1:CAS:528:DC%2BD1MXhtlWltbfJ
44. B Benyamin AF McRae G Zhu, et al. 2009 Variants in Tf and HFE explain approximately 40% of genetic variation in serum-transferrin levels Am J Hum Genet 84 60 65 10.1016/j.ajhg.2008.11.011 19084217 1:CAS:528: DC%2BD1MXpsFarsw%3D%3D
45. S Jacolot G Le Gac V Scotet, et al. 2004 Hamp as a modifier gene that increases the phenotypic expression of the HFE C282Y homozygous genotype Blood 103 2835 2840 10.1182/blood-2003-10-3366 14670915 1:CAS:528:DC%2BD2cXjtVaktro%3D (Pubitemid 38393047)
46. Le Gac G, Scotet V, Ka C, et at.: The recently identified type 2a juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum Mol Genet 2004, 13:1913-1918.
47. J Milet V Dehais C Bourgain, et al. 2007 Common variants in the bmp2, bmp4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance Am J Hum Genet 81 799 807 10.1086/520001 17847004 1:CAS:528:DC%2BD2sXhtFSktrjM (Pubitemid 47603057)
48. H Van Vlierberghe M Langlois J Delanghe, et al. 2001 Haptoglobin phenotype 2-2 overrepresentation in C282Y hemochromatotic patients J Hepatol 35 707 711 10.1016/S0168-8278(01)00203-3 11738096 (Pubitemid 34717660)
49. CH Osterreicher C Datz F Stickel, et al. 2005 TGF-β1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis Cytokine 31 142 148 10.1016/j.cyto.2005.03.005 15941661 1:CAS:528:DC%2BD2MXlvVenu7k%3D (Pubitemid 40910230)
50. R Moirand G Lescoat D Delamaire, et al. 1991 Increase in glycosylated and nonglycosylated serum ferritin in chronic alcoholism and their evolution during alcohol withdrawal Alcohol Clin Exp Res 15 963 969 10.1111/j.1530-0277.1991. tb05196.x 1686373 1:STN:280:DyaK387mtFaitg%3D%3D
51. JE Cade JA Moreton B O'Hara, et al. 2005 Diet and genetic factors associated with iron status in middle-aged women Am J Clin Nutr 82 813 820 16210711 1:CAS:528:DC%2BD2MXhtFeitr7M
52. EA Milward SK Baines MW Knuiman, et al. 2008 Noncitrus fruits as novel dietary environmental modifiers of iron stores in people with or without HFE gene mutations Mayo Clin Proc 83 543 549 10.4065/83.5.543 18452683 (Pubitemid 351717001)
53. PC Adams S Agnew 1996 Alcoholism in hereditary hemochromatosis revisited: Prevalence and clinical consequences among homozygous siblings Hepatology 23 724 727 10.1002/hep.510230411 8666324 1:STN:280:DyaK283jtVSqtg%3D%3D
54. LM Fletcher JL Dixon DM Purdie, et al. 2002 Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis Gastroenterology 122 281 289 10.1053/gast.2002.30992 11832443
55. HH Diwakaran AS Befeler RS Britton, et al. 2002 Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection J Hepatol 36 687 691 10.1016/S0168-8278(02)00018-1 11983453 1:CAS:528:DC%2BD38Xjtl2ksbo%3D (Pubitemid 34499407)
56. EE Powell A Ali AD Clouston, et al. 2005 Steatosis is a cofactor in liver injury in hemochromatosis Gastroenterology 129 1937 1943 10.1053/j.gastro.2005. 09.015 16344062 1:CAS:528:DC%2BD28Xks1Gmtw%3D%3D (Pubitemid 41772971)
57. WH Rogowski 2009 The cost-effectiveness of screening for hereditary hemochromatosis in germany: a remodeling study Med Decis Making 29 224 238 10.1177/0272989X08327112 19182214 This article presents various screening strategies and their cost-effectiveness.